林 聖閎

Medicine & Life Sciences

1. Sjogren's Syndrome 100%
2. Autoimmune Diseases 80%
3. Rheumatoid Arthritis 69%
4. Autoantibodies 61%
5. C1 peptide 59%
6. Peptides 56%
7. Systemic Lupus Erythematosus 51%
8. 2-nonenal 50%
9. Thyroiditis 45%
10. 4-hydroxy-2-nonenal 45%
11. Bisphosphonate-Associated Osteonecrosis of the Jaw 44%
12. RNA Editing 41%
13. Thymectomy 38%
14. Pneumocystis Pneumonia 36%
15. anti-IgM 36%
16. Hip Replacement Arthroplasties 34%
17. Rheumatic Diseases 34%
18. Odds Ratio 34%
19. Histamine Antagonists 34%
20. Proton Pump Inhibitors 33%
21. Autoimmune Haemolytic Anaemia 32%
22. Acetylation 31%
23. anti-IgA 30%
24. Immunoglobulin M 30%
25. Knee Replacement Arthroplasties 30%
26. Biological Products 29%
27. Malondialdehyde 28%
28. Hepatitis B virus 28%
29. Serum 28%
30. Cohort Studies 28%
31. Immunoglobulin A 27%
32. Hepacivirus 27%
33. Glioma 27%
34. Population 26%
35. Virus Diseases 25%
36. Fatty Acids 25%
37. Immunoglobulin G 24%
38. Hepatocellular Carcinoma 23%
39. Inflammation 22%
40. Proportional Hazards Models 21%
41. Systemic Vasculitis 21%
42. Lymphocytes 20%
43. Taiwan 19%
44. Messenger RNA 16%
45. Myasthenia Gravis 16%
46. Ankylosing Spondylitis 16%
47. National Health Programs 15%
48. Proteins 13%
49. Addison Disease 13%
50. Blood Proteins 12%